CLOROX CO /DE/ Quarterly Liabilities and Equity in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Clorox Co /De/ quarterly Liabilities and Equity history and growth rate from Q1 2010 to Q3 2024.
  • Clorox Co /De/ Liabilities and Equity for the quarter ending September 30, 2024 was $5.5B, a 8.25% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $5.5B -$494M -8.25% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $5.75B -$194M -3.26% Jun 30, 2024 10-Q 2024-10-30
Q1 2024 $5.81B -$13M -0.22% Mar 31, 2024 10-Q 2024-04-30
Q4 2023 $5.91B -$137M -2.27% Dec 31, 2023 10-Q 2024-02-01
Q3 2023 $5.99B -$162M -2.63% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $5.95B -$213M -3.46% Jun 30, 2023 10-K 2024-08-08
Q1 2023 $5.82B -$504M -7.97% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $6.05B -$145M -2.34% Dec 31, 2022 10-Q 2023-02-02
Q3 2022 $6.15B -$121M -1.93% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $6.16B -$176M -2.78% Jun 30, 2022 10-K 2023-08-10
Q1 2022 $6.32B -$119M -1.85% Mar 31, 2022 10-Q 2022-05-02
Q4 2021 $6.19B -$665M -9.7% Dec 31, 2021 10-Q 2022-02-03
Q3 2021 $6.27B -$503M -7.42% Sep 30, 2021 10-Q 2021-11-01
Q2 2021 $6.33B +$121M +1.95% Jun 30, 2021 10-K 2022-08-10
Q1 2021 $6.44B +$591M +10.1% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 $6.86B +$1.4B +25.6% Dec 31, 2020 10-Q 2021-02-04
Q3 2020 $6.78B +$1.38B +25.6% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $6.21B +$1.1B +21.4% Jun 30, 2020 10-K 2021-08-10
Q1 2020 $5.85B +$688M +13.3% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $5.46B +$386M +7.61% Dec 31, 2019 10-Q 2020-02-04
Q3 2019 $5.4B +$339M +6.7% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $5.12B +$56M +1.11% Jun 30, 2019 10-K 2020-08-13
Q1 2019 $5.16B -$282M -5.18% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $5.07B +$315M +6.62% Dec 31, 2018 10-Q 2019-02-04
Q3 2018 $5.06B +$458M +9.96% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 $5.06B +$487M +10.6% Jun 30, 2018 10-K 2019-08-14
Q1 2018 $5.44B +$815M +17.6% Mar 31, 2018 10-Q 2018-05-02
Q4 2017 $4.76B +$190M +4.16% Dec 31, 2017 10-Q 2018-02-02
Q3 2017 $4.6B +$134M +3% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 $4.57B +$63M +1.4% Jun 30, 2017 10-K 2018-08-14
Q1 2017 $4.63B +$345M +8.05% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 $4.57B +$393M +9.41% Dec 31, 2016 10-Q 2017-02-03
Q3 2016 $4.47B +$371M +9.06% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 $4.51B +$346M +8.31% Jun 30, 2016 10-K 2017-08-15
Q1 2016 $4.28B +$56M +1.33% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 $4.18B -$499M -10.7% Dec 31, 2015 10-Q 2016-02-04
Q3 2015 $4.1B -$55M -1.33% Sep 30, 2015 10-Q 2015-11-02
Q2 2015 $4.16B -$94M -2.21% Jun 30, 2015 10-K 2016-08-16
Q1 2015 $4.23B -$146M -3.34% Mar 31, 2015 10-Q 2015-05-04
Q4 2014 $4.67B +$286M +6.52% Dec 31, 2014 10-Q 2015-02-05
Q3 2014 $4.15B -$151M -3.51% Sep 30, 2014 10-Q 2014-11-03
Q2 2014 $4.26B -$53M -1.23% Jun 30, 2014 10-K 2015-08-21
Q1 2014 $4.37B -$149M -3.29% Mar 31, 2014 10-Q 2014-05-02
Q4 2013 $4.39B -$114M -2.53% Dec 31, 2013 10-Q 2014-02-05
Q3 2013 $4.3B -$446M -9.4% Sep 30, 2013 10-Q 2013-11-01
Q2 2013 $4.31B -$44M -1.01% Jun 30, 2013 8-K 2014-12-04
Q1 2013 $4.52B +$137M +3.12% Mar 31, 2013 10-Q 2013-05-02
Q4 2012 $4.5B +$212M +4.94% Dec 31, 2012 10-Q 2013-02-05
Q3 2012 $4.75B +$670M +16.4% Sep 30, 2012 10-Q 2012-11-02
Q2 2012 $4.36B +$192M +4.61% Jun 30, 2012 10-K 2013-08-23
Q1 2012 $4.39B +$335M +8.27% Mar 31, 2012 10-Q 2012-05-03
Q4 2011 $4.29B +$132M +3.18% Dec 31, 2011 10-Q 2012-02-06
Q3 2011 $4.08B -$716M -14.9% Sep 30, 2011 10-Q 2011-11-03
Q2 2011 $4.16B -$385M -8.47% Jun 30, 2011 10-K 2012-08-24
Q1 2011 $4.05B -$692M -14.6% Mar 31, 2011 10-Q 2011-05-04
Q4 2010 $4.16B Dec 31, 2010 10-Q 2011-02-07
Q3 2010 $4.79B Sep 30, 2010 10-Q 2010-11-03
Q2 2010 $4.55B Jun 30, 2010 10-K 2011-08-26
Q1 2010 $4.74B Mar 31, 2010 10-Q 2010-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.